Wow.
so the secondary endpoint was acne that hadn't broken the surface yet. They chose that as secondary to the prime target of open lesions but they would be arguably harder to treat. Even the US study good results for the secondary endpoint.
i think the market has totally misunderstood the results
Well worth a listen!, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $645.1M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $1.731M | 4.833M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 105638 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 215555 | 4 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |